2021 American Heart Association (AHA) Scientific Sessions

Epigenetic BET Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Aortic Gene Expression in a DIO Mouse Model. Follow link for poster.

2021 American Society of Nephrology: Kidney Week

Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells: Mechanism for Reduced Cardiac Events in CKD Patients. Follow link for presentation.

14th Clinical Trials on Alzheimer's Disease (CTAD) 2021

Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial. This is the published paper on the same abstract presented at CTAD.

ROC20- THE EPIGENETIC MODULATOR APABETALONE DECREASES NEUROINFLAMMATION IN BLOOD BRAIN BARRIER CELL MODELS AND LPS-TREATED MICE. Follow the link for the complete abstract.